Anti-cancer compounds

US7858349B2 · kind B2 · utility

Assignee

• The Regents of the University of Colorado · US

Inventors

• John M. Stewart · Lawrence, US
• Daniel Chan · Denver, US
• Lajos Gera · Denver, US
• Paul Bunn · Evergreen, US

Key dates

• Filing date: Sep 17, 2008
• Grant date: Dec 28, 2010
• Expiry date: Mar 1, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides bradykinin antagonists and pharmaceutically acceptable salts thereof having anti-cancer activity. These anti-cancer compounds are particularly useful for inhibiting the growth of lung and prostate cancers.